Benign breast papilloma: Is surgical excision necessary?
Authors:
- 14 October 2019
- journal article
- research article
- Published by Wiley in The Breast Journal
- Vol. 26 (4) , 705-710
Abstract
In many centers internationally, current standard of care is to excise all papillomas of the breast, despite recently reported low rates of upgrade to malignancy on final excision. The objective of this study was to determine the upgrade rate to malignancy in patients with papilloma without atypia. A retrospective review of a prospectively maintained database of all cases of benign intraductal papilloma in a tertiary referral symptomatic breast unit between July 2008 and July 2018 was performed. Patients with evidence of malignancy or atypia on core biopsy and those with a history of breast cancer or genetic mutations predisposing to breast cancer were excluded. One hundred and seventy‐three cases of benign papilloma diagnosed on core biopsy were identified. Following exclusions, the final cohort comprised of 138 patients. Mean age at presentation was 51. Mean follow‐up time was 9.6 months. The most common symptom was a lump (40%). Of the 124 patients who underwent excision, three had ductal carcinoma in situ and there were no cases of invasive disease, giving an upgrade rate to malignancy of 2.4%. Upgrade to other high‐risk lesions (atypical lobular and ductal hyperplasia and lobular carcinoma in situ) was demonstrated in 15 cases (12.1%). Benign papilloma was confirmed in 100 cases (81.5%), and 6 (4.8%) had no residual papilloma found on final excision. Twelve patients (8.7%) were managed conservatively. Of those, one later went on to develop malignancy. Patients with a diagnosis of benign papilloma without atypia on core biopsy have a low risk of upgrade to malignancy on final pathology, suggesting that observation may be a safe alternative to surgical excision. Further research is warranted to determine which patients can be safely managed conservatively.Keywords
This publication has 18 references indexed in Scilit:
- Treatment Selection for Patients with Ductal Carcinoma In Situ (DCIS) of the Breast Using the University of Southern California/Van Nuys (USC/VNPI) Prognostic IndexThe Breast Journal, 2015
- Non–mass-associated intraductal papillomas: is excision necessary?Human Pathology, 2014
- Benign Papillomas Without Atypia Diagnosed on Core Needle Biopsy: Experience From a Single Institution and Proposed Criteria for ExcisionClinical Breast Cancer, 2013
- Incidental Intraductal Papillomas (<2 mm) of the Breast Diagnosed on Needle Core Biopsy do not Need to be ExcisedThe Breast Journal, 2013
- Management of Benign Intraductal Solitary Papilloma Diagnosed on Core Needle BiopsyAnnals of Surgical Oncology, 2013
- Management of Papillary Breast Lesions Diagnosed on Core-Needle Biopsy: Clinical Pathologic and Radiologic Analysis of 276 Cases with Surgical Follow-UpJournal of the American College of Surgeons, 2012
- Intraductal papillomas of the breast: Diagnosis and management of 151 patientsThe Breast, 2011
- Management of Intraductal Papillomas of the Breast: An Analysis of 129 Cases and Their OutcomeAnnals of Surgical Oncology, 2009
- Excision is indicated for intraductal papilloma of the breast diagnosed on core needle biopsyCancer, 2009
- Underestimation of the Presence of Breast Carcinoma in Papillary Lesions Initially Diagnosed at Core-Needle BiopsyRadiology, 2007